Earth Science Tech, Inc. (ETST) to Exhibit Hygee™ at the Arab Health Medical Trade Fair in Dubai

DORAL, Florida, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that it will display its leading-edge medical device, Hygee™, at in Dubai, the biggest annual medical trade fair in the Middle East & North Africa (MENA) region.

The Arab Health 2019 fair will take place January 28 – 31, 2019, at the Dubai World Trade Centre, where manufacturers and medical service providers can connect with clinicians, procurement professionals, dealers and distributors. More than 4,000 companies from 66 countries will display at the fair, which is expected to attract over 84,000 visitors and nearly 6,000 dignitaries.

Dermagate, ETST’s manufacturing partner for Hygee™, will officially represent the Company at the fair, introducing Hygee™ to the most important medical distributors in the Middle East and North Africa, ahead of the product’s .

“Introducing Hygee™ at an international event of this caliber is an important element of our product marketing plan,” states Dr. Michel Aubé, CEO and chief science officer of ETST. “We are pleased that Dermagate President Gaétan Houle will represent our brand in Dubai, and we intend to leverage his presence at the show to make key business contacts to connect to the region’s healthcare industry and market.”

Houle will attend the event in conjunction with an eight-company Quebec delegation organized by the Quebec Minister of the Economy and Innovation (“MEI”) and Global Affairs Canada. Houle has been invited to attend a related event at the Canadian Consulate, hosted by the Canadian Trade Commissioner in Chief based in the UAE. Working with the MEI organizer of the Quebec Delegation, Houle will also meet with Canadian Trade commissioners from other MENA countries, including Kuwait and Lebanon.

“, Hygee™ is on its way to being certified IS0-13485 and soon after it will be licensed by the US FDA and Health Canada. Moreover, ETST will apply for licensing Hygee™ in at least 5 other countries. This is notable, as many of North America’s largest medical device companies will attend Arab Health 2019, as will manufacturers and distributors from around the world,” says Houle. “I look forward to representing Earth Science Tech and its incredible Hygee™ device, and establishing relationships that could further brand recognition and networking.”

About Earth Science Tech, Inc. (ETST)

Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.

To learn more, please visit:

ETST currently has four wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors:

Earth Science Pharmaceutical, Inc.

Earth Science Pharmaceutical ("ESP") is a wholly-owned subsidiary of Earth Science Tech, committed to the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP's CEO and chief science officer, Dr. Michel Aubé, is leading the Company’s research and development efforts. The Company’s first medical device, Hygee™, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women. To learn more please visit:

Cannabis Therapeutics, Inc.

Cannabis Therapeutics (“CTI”) is a wholly-owned subsidiary of Earth Science Tech, Inc. poised to take a leadership role in the development of new, leading-edge cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs. To learn more please visit:

KannaBidioiD, Inc.

KannaBidioiD (“KBD”) is a wholly-owned subsidiary of Earth Science Tech, Inc. that provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy. To learn more please visit:

Earth Science Foundation, Inc.

Earth Science Foundation (“ESF”) is a wholly-owned subsidiary of Earth Science Tech, Inc. ESF is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech's effective CBD products to those in need. To learn more please visit:

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:



Nickolas S. Tabraue

President, Director & Chairman

305.615.2118 Office

Corporate Communications Contact:

NetworkNewsWire (NNW)

New York, New York



212.418.1217 Office